Skip to main content

Advertisement

Log in

Response to letter by Masse O et al. STOPP/START version 3: clinical pharmacists are raising alarms

  • Letter to the Editor
  • Published:
European Geriatric Medicine Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 28 February 2024

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. O’Mahony D, Cherubini A, Guiteras AR, Denkinger M, Beuscart JB, Onder G, Gudmundsson A, Cruz-Jentoft AJ, Knol W, Bahat G, van der Velde N, Petrovic M, Curtin D (2023) STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med 14(4):625–632

    Article  PubMed  PubMed Central  Google Scholar 

  2. British National Formulary 81 (2021). BMJ Group & Pharmaceutical Press, London, pp 767–773

  3. https://www.uspharmacist.com/article/bisphosphonate-nephrotoxicity-risks-and-use-in-ckd-patients. Accessed 15 Jan 2024

  4. https://www.ema.europa.eu/en/documents/product-information/ebixa-epar-product-information_en.pdf. Accessed 15 Jan 2024

  5. Evans M, Morgan AR, Davies S, Beba H, Strain WD (2022) The role of sodium-glucose co-transporter-2 inhibitors in frail older adults with or without type 2 diabetes mellitus. Age Ageing 51(10):afac201

    Article  PubMed  PubMed Central  Google Scholar 

  6. Shrestha DB, Budhathoki P, Sedhai YR, Karki P, Gurung S, Raut S, Damonte JI, Del Buono MG, Mojadidi MK, Elgendy IY, Patel T, Patel NK (2021) Sodium-glucose cotransporter-2 inhibitors in heart failure: an updated systematic review and meta-analysis of 13 randomized clinical trials including 14,618 patients with heart failure. J Cardiovasc Pharmacol 78(4):501–514

    Article  CAS  PubMed  Google Scholar 

  7. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, ESC Scientific Document Group (2023) 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 44(37):3627–3639

    Article  CAS  PubMed  Google Scholar 

  8. Seppala LJ, Petrovic M, Ryg J, Bahat G, Topinkova E, Szczerbińska K, van der Cammen TJM, Hartikainen S, Ilhan B, Landi F, Morrissey Y, Mair A, Gutiérrez-Valencia M, Emmelot-Vonk MH, Mora MÁC, Denkinger M, Crome P, Jackson SHD, Correa-Pérez A, Knol W, Soulis G, Gudmundsson A, Ziere G, Wehling M, O’Mahony D, Cherubini A, van der Velde N (2021) STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs. Age Ageing 50(4):1189–1199

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Denis O’Mahony.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Mahony, D., Cherubini, A., Guiteras, A.R. et al. Response to letter by Masse O et al. STOPP/START version 3: clinical pharmacists are raising alarms. Eur Geriatr Med 15, 593–596 (2024). https://doi.org/10.1007/s41999-024-00958-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s41999-024-00958-3

Navigation